Medicare Enrolled

Dr. Edwin Dejesus, MD

Infectious Disease · Orlando, FL
1707 N MILLS AVE, Orlando, FL 32803
4076473960
Registered in NPPES since 2005
NPI: 1295734101 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dejesus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dejesus? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dejesus

Dr. Edwin Dejesus is an infectious disease specialist in Orlando, FL, with 21 years of NPI registration.

Between the years covered by Open Payments, Dr. Dejesus received a total of $90,382 from 26 pharmaceutical and/or device companies across 498 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dejesus is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration $90,382 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 63956 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$90,382
Total received (2018-2024)
Avg $12,912/year across 7 years
Top 3% in FL for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
498
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$782
2023
$536
2022
$8,617
2021
$4,126
2020
$1,370
2019
$25,322
2018
$49,630

Payments by company (2024)

Gilead Sciences, Inc.
$318
ViiV Healthcare Company
$237
Merck Sharp & Dohme LLC
$93
Hologic Sales and Service, LLC
$61
ABBVIE INC.
$34
Theratechnologies Inc.
$23
Insmed, Inc.
$16
Top 3 companies account for 82.8% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$57,920
ViiV Healthcare Company
$11,494
Theratechnologies Inc.
$10,063
Janssen Scientific Affairs, LLC
$8,402
Janssen Biotech, Inc.
$968
Merck Sharp & Dohme Corporation
$618
EMD Serono, Inc.
$179
Merck Sharp & Dohme LLC
$154
Hologic Sales and Service, LLC
$78
AbbVie Inc.
$78
Melinta Therapeutics, Inc.
$77
Insmed, Inc.
$49
Kerecis Limited
$44
ABBVIE INC.
$34
Allergan Inc.
$31
Janssen Products, LP
$30
Astellas Pharma US Inc
$22
Endo Pharmaceuticals Inc.
$20
Aytu Bioscience, Inc
$19
GlaxoSmithKline, LLC.
$17
Mylan Pharmaceuticals Inc.
$17
Seqirus USA Inc
$16
Allergan, Inc.
$15
Amarin Pharma Inc.
$13
AbbVie, Inc.
$12
Aytu BioScience, Inc
$12
Top 3 companies account for 87.9% of all-time payments
Associated products mentioned in payments ›
APRETUDE · APTIMA · Arikayce · Baxdela · Biktarvy · CABENUVA · CRESEMBA · DOVATO · EDURANT · EGRIFTA · Fluad · GARDASIL · ISENTRESS · JULUCA · Kerecis Omega3 SurgiClose · Kerecis Omega3 Wound · MAVYRET · Mavyret · Natesto · PIFELTRO · PNEUMOVAX 23 · PREZCOBIX · RUKOBIA · SELZENTRY · SEROSTIM · SHINGRIX · SYMTUZA · Serostim · Symfi Lo · Symtuza · TEFLARO · TESTOPEL · THINPREP 2000 PROCESSOR · TRIUMEQ · TROGARZO · Truvada · VIBERZI · VRAYLAR · Vabomere · Vascepa · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an infectious disease specialist in Orlando?
Compare infectious diseases in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases in nearby ZIP areas
77
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH ORLANDO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dejesus is an infectious disease specialist, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Dejesus receive payments from pharmaceutical companies?
Yes. Dr. Dejesus received a total of $90,382 from 26 companies across 498 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Dejesus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →